These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9705499)

  • 41. The human DNA polymerase lambda interacts with PCNA through a domain important for DNA primer binding and the interaction is inhibited by p21/WAF1/CIP1.
    Maga G; Blanca G; Shevelev I; Frouin I; Ramadan K; Spadari S; Villani G; Hübscher U
    FASEB J; 2004 Nov; 18(14):1743-5. PubMed ID: 15358682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory roles of p21 and apurinic/apyrimidinic endonuclease 1 in base excision repair.
    Tom S; Ranalli TA; Podust VN; Bambara RA
    J Biol Chem; 2001 Dec; 276(52):48781-9. PubMed ID: 11641413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A tumor necrosis factor alpha- and interleukin 6-inducible protein that interacts with the small subunit of DNA polymerase delta and proliferating cell nuclear antigen.
    He H; Tan CK; Downey KM; So AG
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11979-84. PubMed ID: 11593007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase.
    Roussigne M; Kossida S; Lavigne AC; Clouaire T; Ecochard V; Glories A; Amalric F; Girard JP
    Trends Biochem Sci; 2003 Feb; 28(2):66-9. PubMed ID: 12575992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo.
    Cooper MP; Balajee AS; Bohr VA
    Mol Biol Cell; 1999 Jul; 10(7):2119-29. PubMed ID: 10397753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
    Pustovalova Y; Maciejewski MW; Korzhnev DM
    J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
    Nakanishi M; Robetorye RS; Pereira-Smith OM; Smith JR
    J Biol Chem; 1995 Jul; 270(29):17060-3. PubMed ID: 7615495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.
    Scott MT; Morrice N; Ball KL
    J Biol Chem; 2000 Apr; 275(15):11529-37. PubMed ID: 10753973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation.
    Koundrioukoff S; Jónsson ZO; Hasan S; de Jong RN; van der Vliet PC; Hottiger MO; Hübscher U
    J Biol Chem; 2000 Jul; 275(30):22882-7. PubMed ID: 10930425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.
    Flores-Rozas H; Kelman Z; Dean FB; Pan ZQ; Harper JW; Elledge SJ; O'Donnell M; Hurwitz J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8655-9. PubMed ID: 7915843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MutLalpha and proliferating cell nuclear antigen share binding sites on MutSbeta.
    Iyer RR; Pluciennik A; Genschel J; Tsai MS; Beese LS; Modrich P
    J Biol Chem; 2010 Apr; 285(15):11730-9. PubMed ID: 20154325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A helix-turn-helix DNA-binding motif predicted for transposases of DNA transposons.
    Pietrokovski S; Henikoff S
    Mol Gen Genet; 1997 May; 254(6):689-95. PubMed ID: 9202385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of plu genes and cis-acting elements of PCNA in the Drosophila genus using conservation of gene order.
    Renault AD; Axton JM
    Gene; 2003 Mar; 307():77-86. PubMed ID: 12706890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex.
    Chen U; Chen S; Saha P; Dutta A
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11597-602. PubMed ID: 8876181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p21 Exploits Residue Tyr151 as a Tether for High-Affinity PCNA Binding.
    Kroker AJ; Bruning JB
    Biochemistry; 2015 Jun; 54(22):3483-93. PubMed ID: 25972089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Replication factor C interacts with the C-terminal side of proliferating cell nuclear antigen.
    Mossi R; Jónsson ZO; Allen BL; Hardin SH; Hübscher U
    J Biol Chem; 1997 Jan; 272(3):1769-76. PubMed ID: 8999859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of a second proliferating cell nuclear antigen (PCNA2) from Drosophila melanogaster.
    Ruike T; Takeuchi R; Takata K; Oshige M; Kasai N; Shimanouchi K; Kanai Y; Nakamura R; Sugawara F; Sakaguchi K
    FEBS J; 2006 Nov; 273(22):5062-73. PubMed ID: 17087725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
    Luo Y; Hurwitz J; Massagué J
    Nature; 1995 May; 375(6527):159-61. PubMed ID: 7753174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three proliferating cell nuclear antigen-like proteins found in the hyperthermophilic archaeon Aeropyrum pernix: interactions with the two DNA polymerases.
    Daimon K; Kawarabayasi Y; Kikuchi H; Sako Y; Ishino Y
    J Bacteriol; 2002 Feb; 184(3):687-94. PubMed ID: 11790738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterisation of the interaction between PCNA and Gadd45.
    Hall PA; Kearsey JM; Coates PJ; Norman DG; Warbrick E; Cox LS
    Oncogene; 1995 Jun; 10(12):2427-33. PubMed ID: 7784094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.